Thurston, Springer, Miller, Herd & Titak, Inc. Guardant Health, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $283 Million
- Q2 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 842 shares of GH stock, worth $23,281. This represents 0.01% of its overall portfolio holdings.
Number of Shares
842Holding current value
$23,281% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
309Shares Held
110MCall Options Held
2.51MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA11.4MShares$316 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$305 Million0.01% of portfolio
-
Baillie Gifford & CO6.23MShares$172 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$166 Million4.09% of portfolio
-
Cadian Capital Management, LP New York, NY5.79MShares$160 Million4.28% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.83B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...